| Literature DB >> 15664824 |
Mary M Mader1, Chuan Shih, Eileen Considine, Alfonso De Dios, Cora Sue Grossman, Philip A Hipskind, Ho-Shen Lin, Karen L Lobb, Beatriz Lopez, José E Lopez, Luisa M Martin Cabrejas, Michael E Richett, Wesley T White, Yiu-Yin Cheung, Zhongping Huang, John E Reilly, Sean R Dinn.
Abstract
The anti-proliferative activity of acylated heterocyclic sulfonamides is described in Vascular Endothelial Growth Factor-dependent Human Umbilical Vascular Endothelial Cells (VEGF-HUVEC) and in HCT116 tumor cells in a soft agar diffusion assay.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15664824 DOI: 10.1016/j.bmcl.2004.11.041
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823